Clinical Trial Update: Critical Respiratory Events in Children Requiring Naloxone: Naloxone Use as Opioid Safety Measure

View source ↗

Summary

This completed clinical trial evaluates naloxone use as a safety measure in children with opioid-induced respiratory depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-induced Respiratory Depression

Drugs mentioned

• Naloxone (Naloxone)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Opioid Induced Respiratory Depression | Status: COMPLETED